BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 4, 2021
View Archived Issues
China's NMPA accepts Kintor's IND for topical AR degrader GT-20029
Read More
FDA authorizes initiation of pivotal phase III study of NE-3107 in AD
Read More
A bivalent measles-based COVID-19 vaccine shows antiviral efficacy in vivo and Th1-biased responses
Read More
Multivalent nanobodies potently neutralize SARS-CoV-2 and prevent mutational escape
Read More
Positive topline data from phase II study of Allocetra in severe and critical COVID-19
Read More
Crinetics initiates phase I study of CRN-04777
Read More
Preliminary phase I data show safety and immunogenicity of VXA-CoV2-1 oral tablet vaccine
Read More
New cannabinoid CB1 and CB2 receptor ligands identified at Canopy Growth Corp.
Read More
Cybrexa 3 patents peptide conjugates of microtubule-targeting agents
Read More
Novartis discovers AKR1C3-dependent GTPase KRAS inhibitors
Read More
California Institute of Technology, Rockefeller University describe anti-HIV vaccine antibodies
Read More
Phase Ib data show lack of objective response for CMP-001 plus atezolizumab in NSCLC
Read More
RCC-33 reduces tumor volume in mice inoculated with colorectal cancer cells
Read More
ABTL-0812 plus paclitaxel and carboplatin result in increased efficacy in NSCLC
Read More
ViaCyte begins phase II study of VC01-103 in type 1 diabetes
Read More
JADE family of markers has prognostic value in NSCLC
Read More
New dengue virus inhibitor shows preclinical promise
Read More
CRY1 protein activators allow circadian clock manipulation with light
Read More
Roche discloses new monoglyceride lipase inhibitors
Read More
Erlotinib plus anlotinib shows promise in EGFR-mutated NSCLC
Read More
FDA grants accelerated approval to Tepmetko for metastatic NSCLC with METex14 skipping alterations
Read More
Daiichi Sankyo initiates phase II study of patritumab deruxtecan in EGFR-mutated NSCLC
Read More